Molecular Weight:   | 137.08 |
Volume:   | 150.245 |
LogP:   | 0.311 |
LogD:   | 0.424 |
LogS:   | -0.616 |
# Rotatable Bonds:   | 2 |
TPSA:   | 46.25 |
# H-Bond Aceptor:   | 2 |
# H-Bond Donor:   | 3 |
# Rings:   | 1 |
# Heavy Atoms:   | 2 |
QED Drug-Likeness Score:   | 0.636 |
Synthetic Accessibility Score:   | 1.625 |
Fsp3:   | 0.25 |
Lipinski Rule-of-5:   | Accepted |
Pfizer Rule:   | Accepted |
GSK Rule:   | Accepted |
BMS Rule:   | 0 |
Golden Triangle Rule:   | Rejected |
Chelating Alert:   | 0 |
PAINS Alert:   | 0 |
Caco-2 Permeability:   | -4.863 |
MDCK Permeability:   | 7.20978932804428e-05 |
Pgp-inhibitor:   | 0.0 |
Pgp-substrate:   | 0.006 |
Human Intestinal Absorption (HIA):   | 0.624 |
20% Bioavailability (F20%):   | 0.891 |
30% Bioavailability (F30%):   | 0.629 |
Blood-Brain-Barrier Penetration (BBB):   | 0.181 |
Plasma Protein Binding (PPB):   | 16.950313568115234% |
Volume Distribution (VD):   | 2.958 |
Pgp-substrate:   | 75.18946838378906% |
CYP1A2-inhibitor:   | 0.401 |
CYP1A2-substrate:   | 0.755 |
CYP2C19-inhibitor:   | 0.093 |
CYP2C19-substrate:   | 0.158 |
CYP2C9-inhibitor:   | 0.023 |
CYP2C9-substrate:   | 0.832 |
CYP2D6-inhibitor:   | 0.436 |
CYP2D6-substrate:   | 0.909 |
CYP3A4-inhibitor:   | 0.021 |
CYP3A4-substrate:   | 0.241 |
Clearance (CL):   | 13.101 |
Half-life (T1/2):   | 0.851 |
hERG Blockers:   | 0.133 |
Human Hepatotoxicity (H-HT):   | 0.165 |
Drug-inuced Liver Injury (DILI):   | 0.026 |
AMES Toxicity:   | 0.101 |
Rat Oral Acute Toxicity:   | 0.926 |
Maximum Recommended Daily Dose:   | 0.402 |
Skin Sensitization:   | 0.873 |
Carcinogencity:   | 0.091 |
Eye Corrosion:   | 0.962 |
Eye Irritation:   | 0.45 |
Respiratory Toxicity:   | 0.813 |
Natural Product ID:   | NPC125732 |
Common Name*:   | Tyramine |
IUPAC Name:   | 4-(2-aminoethyl)phenol |
Synonyms:   | Tyramine |
Standard InCHIKey:   | DZGWFCGJZKJUFP-UHFFFAOYSA-N |
Standard InCHI:   | InChI=1S/C8H11NO/c9-6-5-7-1-3-8(10)4-2-7/h1-4,10H,5-6,9H2 |
SMILES:   | c1cc(ccc1CCN)O |
Synthetic Gene Cluster:   | n.a. |
ChEMBL Identifier:   | CHEMBL11608 |
PubChem CID:   |
5610 |
Chemical Classification**:   |
|
*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.
Organism ID | Organism Name | Taxonomy Level | Family | SuperKingdom | Isolation Part | Collection Location | Collection Time | Reference |
---|
☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
☉ UNPD: Universal Natural Products Database [PMID: 23638153].
☉ StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
☉ TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
☉ TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
☉ TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
☉ TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
☉ HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
☉ MetaboLights: a metabolomics database [PMID: 27010336].
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Organism ID | NP ID | Organism Material Preparation | Organism Part | NP Quantity (Standard) | NP Quantity (Minimum) | NP Quantity (Maximum) | Quantity Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPO21556 | NPC125732 | n.a. | Sclerotia | 0.070 ± 0.015 | n.a. | n.a. | % |
PMID[20527951] |
☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
☉ DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
☉ PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
☉ FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT2805 | Individual Protein | Dopamine beta-hydroxylase | Bos taurus | Km | = | 2000000.0 | nM | PMID[515557] |
NPT2805 | Individual Protein | Dopamine beta-hydroxylase | Bos taurus | k cat | = | 85.0 | s-1 | PMID[515557] |
NPT243 | Individual Protein | Dopamine D2 receptor | Homo sapiens | Ki | > | 17000.0 | nM | PMID[515559] |
NPT245 | Individual Protein | Dopamine D4 receptor | Homo sapiens | Ki | > | 35000.0 | nM | PMID[515559] |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Ki | = | 390000.0 | nM | PMID[515560] |
NPT243 | Individual Protein | Dopamine D2 receptor | Homo sapiens | Ki | = | 160000.0 | nM | PMID[515560] |
NPT1528 | Individual Protein | Phenylethanolamine N-methyltransferase | Bos taurus | Ki | = | 294000.0 | nM | PMID[515561] |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | KL | = | 390000.0 | nM | PMID[515562] |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Log 1/KL | = | -5.59 | n.a. | PMID[515562] |
NPT2805 | Individual Protein | Dopamine beta-hydroxylase | Bos taurus | Km | = | 2000000.0 | nM | PMID[515564] |
NPT2805 | Individual Protein | Dopamine beta-hydroxylase | Bos taurus | k cat | = | 121.0 | s-1 | PMID[515564] |
NPT2805 | Individual Protein | Dopamine beta-hydroxylase | Bos taurus | Ratio | = | 60000.0 | n.a. | PMID[515564] |
NPT1779 | Individual Protein | Serotonin 2b (5-HT2b) receptor | Rattus norvegicus | Kd | = | 7943.28 | nM | PMID[515565] |
NPT425 | Individual Protein | Serotonin 3a (5-HT3a) receptor | Homo sapiens | EC50 | = | 26000.0 | nM | PMID[515568] |
NPT43 | Individual Protein | Tyrosinase | Agaricus bisporus | Activity | = | 25.9 | /s | PMID[515571] |
NPT48 | Individual Protein | Lysine-specific demethylase 4D-like | Homo sapiens | Potency | = | 35481.3 | nM | PMID[515572] |
NPT213 | Individual Protein | Cytochrome P450 2C19 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[515573] |
NPT583 | Individual Protein | Inositol monophosphatase 1 | Rattus norvegicus | Potency | = | 31622.8 | nM | PMID[515572] |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | n.a. | 751.9 | nM | PMID[515574] |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | n.a. | 29.1 | nM | PMID[515574] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | Km | = | 514000.0 | nM | PMID[515576] |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | Km | = | 104700.0 | nM | PMID[515576] |
NPT261 | Individual Protein | Monoamine oxidase A | Homo sapiens | Vmax | = | 301.4 | nmol/min/mg | PMID[515576] |
NPT582 | Individual Protein | Monoamine oxidase B | Homo sapiens | Vmax | = | 28.9 | nmol/min/mg | PMID[515576] |
NPT1153 | Individual Protein | Monocarboxylate transporter 10 | Rattus norvegicus | Activity | = | 20.0 | % | PMID[515578] |
NPT613 | Individual Protein | Solute carrier family 22 member 1 | Homo sapiens | Activity | = | 107.0 | uM | PMID[515580] |
NPT10 | Individual Protein | Geminin | Homo sapiens | Potency | n.a. | 6513.1 | nM | PMID[515572] |
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | n.a. | 10000.0 | nM | PMID[515572] |
NPT100 | Individual Protein | Glutaminase kidney isoform, mitochondrial | Homo sapiens | Potency | n.a. | 7943.3 | nM | PMID[515575] |
NPT242 | Individual Protein | Dopamine D1 receptor | Homo sapiens | Potency | n.a. | 8199.5 | nM | PMID[515574] |
NPT50 | Individual Protein | Tyrosyl-DNA phosphodiesterase 1 | Homo sapiens | Potency | n.a. | 32642.7 | nM | PMID[515572] |
NPT43 | Individual Protein | Tyrosinase | Agaricus bisporus | Km | = | 540000.0 | nM | PMID[515583] |
NPT244 | Individual Protein | Dopamine D3 receptor | Homo sapiens | Potency | n.a. | 28183.8 | nM | PMID[515572] |
NPT4320 | Individual Protein | Trace amine-associated receptor 1 | Rattus norvegicus | EC50 | = | 69.0 | nM | PMID[515588] |
NPT2 | Others | Unspecified | Potency | n.a. | 6007 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | n.a. | 16930.1 | nM | PubChem BioAssay data set | |
NPT4410 | Others | Opioid receptor (mu and kappa) | Cavia porcellus | Ratio | < | 0.00007 | n.a. | PMID[515556] |
NPT4410 | Others | Opioid receptor (mu and kappa) | Cavia porcellus | EC50 | > | 0.001 | n.a. | PMID[515556] |
NPT3590 | Protein Family | Opioid receptor | Rattus norvegicus | EC50 | > | 0.001 | n.a. | PMID[515556] |
NPT3590 | Protein Family | Opioid receptor | Rattus norvegicus | Ratio | < | 0.000087 | n.a. | PMID[515556] |
NPT2 | Others | Unspecified | Ratio | = | 42000.0 | M-1 s-1 | PMID[515557] | |
NPT1530 | Protein Family | Serotonin (5-HT) receptor | Rattus norvegicus | Kd | = | 8511.38 | nM | PMID[515558] |
NPT2 | Others | Unspecified | -Log KD | = | -2.3 | n.a. | PMID[515563] | |
NPT1530 | Protein Family | Serotonin (5-HT) receptor | Rattus norvegicus | Kd | = | 8511.38 | nM | PMID[515565] |
NPT741 | Individual Protein | Tyrosinase | Homo sapiens | Inhibition | = | 23.0 | % | PMID[515566] |
NPT740 | Individual Protein | Beta-secretase 1 | Homo sapiens | Kd | = | 2000000.0 | nM | PMID[515567] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | IC50 | = | 160000.0 | nM | PMID[515569] |
NPT976 | Individual Protein | Trace amine-associated receptor 1 | Homo sapiens | EC50 | = | 731.0 | nM | PMID[515570] |
NPT976 | Individual Protein | Trace amine-associated receptor 1 | Homo sapiens | Emax | = | 91.0 | % | PMID[515570] |
NPT94 | Individual Protein | Aldehyde dehydrogenase 1A1 | Homo sapiens | Potency | = | 39810.7 | nM | PMID[515572] |
NPT2 | Others | Unspecified | Potency | = | 18356.4 | nM | PMID[515572] | |
NPT864 | Individual Protein | Lethal(3)malignant brain tumor-like protein 1 | Homo sapiens | Potency | = | 12589.3 | nM | PMID[515572] |
NPT95 | Individual Protein | Muscarinic acetylcholine receptor M1 | Rattus norvegicus | Potency | = | 50.1 | nM | PMID[515573] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 3.3 | nM | PMID[515572] |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | n.a. | 4256.2 | nM | PMID[515575] |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | n.a. | 266.5 | nM | PMID[515574] |
NPT698 | Individual Protein | Regulator of G-protein signaling 4 | Homo sapiens | Potency | n.a. | 6.7 | nM | PMID[515575] |
NPT35 | Others | n.a. | EC50 | > | 29902.0 | nM | PMID[515572] | |
NPT976 | Individual Protein | Trace amine-associated receptor 1 | Homo sapiens | IC50 | = | 881.84 | nM | PMID[515572] |
NPT35 | Others | n.a. | IC50 | > | 29902.0 | nM | PMID[515572] | |
NPT976 | Individual Protein | Trace amine-associated receptor 1 | Homo sapiens | EC50 | = | 177.71 | nM | PMID[515572] |
NPT2645 | Organism | Giardia intestinalis | Giardia intestinalis | IC50 | = | 68.9 | ug.mL-1 | PMID[515581] |
NPT3535 | Organism | Entamoeba histolytica HM-1:IMSS | Entamoeba histolytica HM-1:IMSS | IC50 | = | 54.2 | ug.mL-1 | PMID[515581] |
NPT73 | Individual Protein | Solute carrier organic anion transporter family member 1B1 | Homo sapiens | Inhibition | = | 59.9 | % | PMID[515582] |
NPT72 | Individual Protein | Solute carrier organic anion transporter family member 1B3 | Homo sapiens | Inhibition | = | 85.38 | % | PMID[515582] |
NPT2 | Others | Unspecified | Potency | n.a. | 31622.8 | nM | PMID[515585] | |
NPT2 | Others | Unspecified | pKb | < | 3.7 | n.a. | PMID[515586] | |
NPT2 | Others | Unspecified | Ac50 | n.a. | 0.631 | uM | PMID[515587] | |
NPT2 | Others | Unspecified | AC50 | n.a. | 631.0 | nM | PMID[515587] | |
NPT605 | Organism | Homo sapiens | Homo sapiens | DILI_severity_class | = | 0.0 | n.a. | PMID[515589] |
NPT20556 | SINGLE PROTEIN | Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 7.67 | % | PMID[515590] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | Inhibition | = | 0.15 | % | PMID[515591] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 20000.0 | nM | PMID[515592] |
NPT20555 | ORGANISM | SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 | IC50 | > | 19952.62 | nM | PMID[515592] |
☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.
Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC125732 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9278 | High Similarity | NPC68055 |
0.9271 | High Similarity | NPC29601 |
0.9109 | High Similarity | NPC145638 |
0.9109 | High Similarity | NPC290566 |
0.9072 | High Similarity | NPC289381 |
0.9072 | High Similarity | NPC155847 |
0.8889 | High Similarity | NPC178902 |
0.8846 | High Similarity | NPC146422 |
0.8762 | High Similarity | NPC59387 |
0.8696 | High Similarity | NPC175313 |
0.8673 | High Similarity | NPC107619 |
0.8627 | High Similarity | NPC231705 |
0.8602 | High Similarity | NPC197783 |
0.8598 | High Similarity | NPC10286 |
0.8598 | High Similarity | NPC213 |
0.8587 | High Similarity | NPC265146 |
0.8544 | High Similarity | NPC142297 |
0.8529 | High Similarity | NPC42383 |
0.8519 | High Similarity | NPC188867 |
0.8519 | High Similarity | NPC281686 |
0.8519 | High Similarity | NPC106551 |
0.8511 | High Similarity | NPC23167 |
0.8495 | Intermediate Similarity | NPC248817 |
0.8462 | Intermediate Similarity | NPC153690 |
0.8462 | Intermediate Similarity | NPC96224 |
0.8462 | Intermediate Similarity | NPC24101 |
0.8421 | Intermediate Similarity | NPC25493 |
0.8421 | Intermediate Similarity | NPC113460 |
0.8387 | Intermediate Similarity | NPC124436 |
0.8381 | Intermediate Similarity | NPC258056 |
0.8367 | Intermediate Similarity | NPC20142 |
0.8367 | Intermediate Similarity | NPC215351 |
0.8364 | Intermediate Similarity | NPC85276 |
0.8333 | Intermediate Similarity | NPC280347 |
0.8333 | Intermediate Similarity | NPC242240 |
0.8333 | Intermediate Similarity | NPC115803 |
0.8333 | Intermediate Similarity | NPC258219 |
0.8333 | Intermediate Similarity | NPC318325 |
0.8333 | Intermediate Similarity | NPC177420 |
0.8333 | Intermediate Similarity | NPC123273 |
0.8316 | Intermediate Similarity | NPC184169 |
0.8302 | Intermediate Similarity | NPC474149 |
0.8288 | Intermediate Similarity | NPC283760 |
0.8288 | Intermediate Similarity | NPC239697 |
0.8286 | Intermediate Similarity | NPC97811 |
0.8247 | Intermediate Similarity | NPC55561 |
0.8247 | Intermediate Similarity | NPC151764 |
0.8247 | Intermediate Similarity | NPC300017 |
0.8229 | Intermediate Similarity | NPC104216 |
0.8214 | Intermediate Similarity | NPC115627 |
0.8214 | Intermediate Similarity | NPC118522 |
0.8214 | Intermediate Similarity | NPC169207 |
0.8211 | Intermediate Similarity | NPC155393 |
0.8208 | Intermediate Similarity | NPC172046 |
0.8163 | Intermediate Similarity | NPC155908 |
0.8163 | Intermediate Similarity | NPC304541 |
0.8163 | Intermediate Similarity | NPC45040 |
0.8144 | Intermediate Similarity | NPC98772 |
0.8142 | Intermediate Similarity | NPC318357 |
0.8125 | Intermediate Similarity | NPC407 |
0.8125 | Intermediate Similarity | NPC307235 |
0.8119 | Intermediate Similarity | NPC290515 |
0.8119 | Intermediate Similarity | NPC164514 |
0.8119 | Intermediate Similarity | NPC108606 |
0.8119 | Intermediate Similarity | NPC226096 |
0.8119 | Intermediate Similarity | NPC303611 |
0.8108 | Intermediate Similarity | NPC137096 |
0.8081 | Intermediate Similarity | NPC325292 |
0.8081 | Intermediate Similarity | NPC138117 |
0.8041 | Intermediate Similarity | NPC27974 |
0.8036 | Intermediate Similarity | NPC317784 |
0.8036 | Intermediate Similarity | NPC142638 |
0.8019 | Intermediate Similarity | NPC186469 |
0.8 | Intermediate Similarity | NPC316301 |
0.8 | Intermediate Similarity | NPC142599 |
0.8 | Intermediate Similarity | NPC128062 |
0.8 | Intermediate Similarity | NPC27323 |
0.8 | Intermediate Similarity | NPC118202 |
0.8 | Intermediate Similarity | NPC151715 |
0.798 | Intermediate Similarity | NPC204210 |
0.798 | Intermediate Similarity | NPC270547 |
0.7931 | Intermediate Similarity | NPC140359 |
0.7931 | Intermediate Similarity | NPC13020 |
0.7928 | Intermediate Similarity | NPC317254 |
0.7921 | Intermediate Similarity | NPC274678 |
0.7921 | Intermediate Similarity | NPC26244 |
0.7921 | Intermediate Similarity | NPC8392 |
0.7921 | Intermediate Similarity | NPC313650 |
0.7917 | Intermediate Similarity | NPC286904 |
0.7917 | Intermediate Similarity | NPC150837 |
0.7913 | Intermediate Similarity | NPC27581 |
0.7909 | Intermediate Similarity | NPC26524 |
0.79 | Intermediate Similarity | NPC181709 |
0.7885 | Intermediate Similarity | NPC327226 |
0.7879 | Intermediate Similarity | NPC192 |
0.7879 | Intermediate Similarity | NPC300478 |
0.7857 | Intermediate Similarity | NPC82963 |
0.7843 | Intermediate Similarity | NPC473388 |
0.7843 | Intermediate Similarity | NPC216520 |
0.7843 | Intermediate Similarity | NPC292730 |
0.7843 | Intermediate Similarity | NPC202986 |
0.7843 | Intermediate Similarity | NPC82664 |
0.7843 | Intermediate Similarity | NPC132271 |
0.7826 | Intermediate Similarity | NPC326079 |
0.7822 | Intermediate Similarity | NPC32977 |
0.7822 | Intermediate Similarity | NPC81010 |
0.78 | Intermediate Similarity | NPC306074 |
0.7797 | Intermediate Similarity | NPC318965 |
0.7788 | Intermediate Similarity | NPC311737 |
0.7788 | Intermediate Similarity | NPC283468 |
0.7788 | Intermediate Similarity | NPC38458 |
0.7778 | Intermediate Similarity | NPC318777 |
0.7778 | Intermediate Similarity | NPC70436 |
0.7767 | Intermediate Similarity | NPC109955 |
0.7767 | Intermediate Similarity | NPC77492 |
0.7767 | Intermediate Similarity | NPC260000 |
0.7767 | Intermediate Similarity | NPC225464 |
0.7767 | Intermediate Similarity | NPC32674 |
0.7767 | Intermediate Similarity | NPC315921 |
0.7745 | Intermediate Similarity | NPC286006 |
0.7736 | Intermediate Similarity | NPC304761 |
0.7736 | Intermediate Similarity | NPC150254 |
0.7736 | Intermediate Similarity | NPC226778 |
0.7736 | Intermediate Similarity | NPC147000 |
0.7731 | Intermediate Similarity | NPC236347 |
0.7731 | Intermediate Similarity | NPC323775 |
0.7727 | Intermediate Similarity | NPC21890 |
0.7723 | Intermediate Similarity | NPC271440 |
0.7723 | Intermediate Similarity | NPC147284 |
0.7723 | Intermediate Similarity | NPC210497 |
0.7723 | Intermediate Similarity | NPC3358 |
0.7723 | Intermediate Similarity | NPC306884 |
0.7723 | Intermediate Similarity | NPC162314 |
0.7723 | Intermediate Similarity | NPC55903 |
0.7723 | Intermediate Similarity | NPC94139 |
0.7719 | Intermediate Similarity | NPC122009 |
0.7692 | Intermediate Similarity | NPC80027 |
0.7692 | Intermediate Similarity | NPC122005 |
0.7692 | Intermediate Similarity | NPC245561 |
0.7692 | Intermediate Similarity | NPC280869 |
0.7692 | Intermediate Similarity | NPC132078 |
0.7692 | Intermediate Similarity | NPC128723 |
0.7692 | Intermediate Similarity | NPC92730 |
0.7692 | Intermediate Similarity | NPC78119 |
0.7692 | Intermediate Similarity | NPC216468 |
0.7692 | Intermediate Similarity | NPC51333 |
0.7692 | Intermediate Similarity | NPC252821 |
0.7677 | Intermediate Similarity | NPC19680 |
0.7667 | Intermediate Similarity | NPC145888 |
0.7667 | Intermediate Similarity | NPC161593 |
0.7667 | Intermediate Similarity | NPC16031 |
0.7652 | Intermediate Similarity | NPC319950 |
0.7652 | Intermediate Similarity | NPC268572 |
0.7647 | Intermediate Similarity | NPC152415 |
0.7647 | Intermediate Similarity | NPC76938 |
0.7647 | Intermediate Similarity | NPC245187 |
0.7632 | Intermediate Similarity | NPC120075 |
0.7624 | Intermediate Similarity | NPC231150 |
0.7619 | Intermediate Similarity | NPC225506 |
0.7619 | Intermediate Similarity | NPC52472 |
0.7619 | Intermediate Similarity | NPC213730 |
0.7603 | Intermediate Similarity | NPC325651 |
0.7596 | Intermediate Similarity | NPC201967 |
0.7573 | Intermediate Similarity | NPC32714 |
0.7573 | Intermediate Similarity | NPC144682 |
0.7573 | Intermediate Similarity | NPC107522 |
0.7547 | Intermediate Similarity | NPC91461 |
0.7547 | Intermediate Similarity | NPC7686 |
0.7547 | Intermediate Similarity | NPC110764 |
0.7547 | Intermediate Similarity | NPC40258 |
0.7541 | Intermediate Similarity | NPC474087 |
0.7525 | Intermediate Similarity | NPC312304 |
0.7525 | Intermediate Similarity | NPC47950 |
0.7524 | Intermediate Similarity | NPC171843 |
0.7524 | Intermediate Similarity | NPC131587 |
0.7524 | Intermediate Similarity | NPC275104 |
0.7524 | Intermediate Similarity | NPC130193 |
0.7521 | Intermediate Similarity | NPC284078 |
0.75 | Intermediate Similarity | NPC312132 |
0.75 | Intermediate Similarity | NPC259512 |
0.75 | Intermediate Similarity | NPC43275 |
0.748 | Intermediate Similarity | NPC48909 |
0.748 | Intermediate Similarity | NPC326966 |
0.748 | Intermediate Similarity | NPC326599 |
0.748 | Intermediate Similarity | NPC329595 |
0.7477 | Intermediate Similarity | NPC470202 |
0.7477 | Intermediate Similarity | NPC135784 |
0.7477 | Intermediate Similarity | NPC196479 |
0.7477 | Intermediate Similarity | NPC168829 |
0.7476 | Intermediate Similarity | NPC289769 |
0.7458 | Intermediate Similarity | NPC142577 |
0.7458 | Intermediate Similarity | NPC474862 |
0.7456 | Intermediate Similarity | NPC222982 |
0.7456 | Intermediate Similarity | NPC160179 |
0.7453 | Intermediate Similarity | NPC253746 |
0.7453 | Intermediate Similarity | NPC211885 |
0.7453 | Intermediate Similarity | NPC248573 |
0.7453 | Intermediate Similarity | NPC275053 |
0.7453 | Intermediate Similarity | NPC223393 |
0.7453 | Intermediate Similarity | NPC161571 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC125732 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
0.9583 | High Similarity | NPD9608 | Approved |
0.9583 | High Similarity | NPD9610 | Approved |
0.9109 | High Similarity | NPD9380 | Clinical (unspecified phase) |
0.8846 | High Similarity | NPD9379 | Approved |
0.8846 | High Similarity | NPD9377 | Approved |
0.8519 | High Similarity | NPD9568 | Approved |
0.844 | Intermediate Similarity | NPD317 | Approved |
0.844 | Intermediate Similarity | NPD16 | Approved |
0.844 | Intermediate Similarity | NPD318 | Approved |
0.844 | Intermediate Similarity | NPD856 | Approved |
0.8387 | Intermediate Similarity | NPD111 | Approved |
0.8333 | Intermediate Similarity | NPD9618 | Approved |
0.8333 | Intermediate Similarity | NPD9614 | Approved |
0.8214 | Intermediate Similarity | NPD9384 | Approved |
0.8214 | Intermediate Similarity | NPD9381 | Approved |
0.8119 | Intermediate Similarity | NPD9612 | Approved |
0.8119 | Intermediate Similarity | NPD9611 | Approved |
0.8119 | Intermediate Similarity | NPD9609 | Approved |
0.8108 | Intermediate Similarity | NPD9613 | Approved |
0.8108 | Intermediate Similarity | NPD9616 | Approved |
0.8108 | Intermediate Similarity | NPD9615 | Approved |
0.8095 | Intermediate Similarity | NPD1444 | Approved |
0.8095 | Intermediate Similarity | NPD1445 | Approved |
0.8091 | Intermediate Similarity | NPD256 | Approved |
0.8091 | Intermediate Similarity | NPD255 | Approved |
0.8073 | Intermediate Similarity | NPD2228 | Approved |
0.8073 | Intermediate Similarity | NPD2229 | Approved |
0.8073 | Intermediate Similarity | NPD2234 | Approved |
0.8036 | Intermediate Similarity | NPD316 | Approved |
0.8 | Intermediate Similarity | NPD2934 | Approved |
0.8 | Intermediate Similarity | NPD1432 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD2561 | Approved |
0.8 | Intermediate Similarity | NPD2933 | Approved |
0.8 | Intermediate Similarity | NPD2562 | Approved |
0.7931 | Intermediate Similarity | NPD9622 | Approved |
0.7921 | Intermediate Similarity | NPD2859 | Approved |
0.7921 | Intermediate Similarity | NPD2860 | Approved |
0.787 | Intermediate Similarity | NPD1792 | Phase 2 |
0.7863 | Intermediate Similarity | NPD5310 | Approved |
0.7863 | Intermediate Similarity | NPD5311 | Approved |
0.7863 | Intermediate Similarity | NPD9634 | Clinical (unspecified phase) |
0.7826 | Intermediate Similarity | NPD2688 | Clinical (unspecified phase) |
0.7797 | Intermediate Similarity | NPD1131 | Approved |
0.7797 | Intermediate Similarity | NPD1133 | Approved |
0.7797 | Intermediate Similarity | NPD3053 | Approved |
0.7797 | Intermediate Similarity | NPD3055 | Approved |
0.7797 | Intermediate Similarity | NPD1135 | Approved |
0.7797 | Intermediate Similarity | NPD1129 | Approved |
0.7797 | Intermediate Similarity | NPD1134 | Approved |
0.7767 | Intermediate Similarity | NPD9273 | Approved |
0.7736 | Intermediate Similarity | NPD314 | Approved |
0.7736 | Intermediate Similarity | NPD310 | Approved |
0.7736 | Intermediate Similarity | NPD309 | Approved |
0.7736 | Intermediate Similarity | NPD315 | Approved |
0.7736 | Intermediate Similarity | NPD10 | Approved |
0.7736 | Intermediate Similarity | NPD311 | Approved |
0.7731 | Intermediate Similarity | NPD2194 | Approved |
0.7731 | Intermediate Similarity | NPD9619 | Approved |
0.7731 | Intermediate Similarity | NPD9621 | Approved |
0.7731 | Intermediate Similarity | NPD9620 | Approved |
0.7731 | Intermediate Similarity | NPD7451 | Discontinued |
0.7731 | Intermediate Similarity | NPD2195 | Approved |
0.7692 | Intermediate Similarity | NPD3020 | Approved |
0.7679 | Intermediate Similarity | NPD1793 | Approved |
0.7679 | Intermediate Similarity | NPD1791 | Approved |
0.7667 | Intermediate Similarity | NPD9569 | Approved |
0.7652 | Intermediate Similarity | NPD4093 | Discontinued |
0.7573 | Intermediate Similarity | NPD1809 | Phase 2 |
0.7573 | Intermediate Similarity | NPD844 | Approved |
0.7565 | Intermediate Similarity | NPD5303 | Approved |
0.7565 | Intermediate Similarity | NPD5304 | Approved |
0.7563 | Intermediate Similarity | NPD196 | Phase 1 |
0.7549 | Intermediate Similarity | NPD845 | Approved |
0.7547 | Intermediate Similarity | NPD846 | Approved |
0.7547 | Intermediate Similarity | NPD940 | Approved |
0.7541 | Intermediate Similarity | NPD3136 | Phase 2 |
0.7522 | Intermediate Similarity | NPD595 | Approved |
0.7522 | Intermediate Similarity | NPD593 | Approved |
0.75 | Intermediate Similarity | NPD288 | Approved |
0.748 | Intermediate Similarity | NPD601 | Approved |
0.748 | Intermediate Similarity | NPD597 | Approved |
0.748 | Intermediate Similarity | NPD2028 | Clinical (unspecified phase) |
0.748 | Intermediate Similarity | NPD598 | Approved |
0.7453 | Intermediate Similarity | NPD1242 | Phase 1 |
0.7436 | Intermediate Similarity | NPD1751 | Approved |
0.7436 | Intermediate Similarity | NPD5238 | Clinical (unspecified phase) |
0.7419 | Intermediate Similarity | NPD6407 | Approved |
0.7419 | Intermediate Similarity | NPD259 | Phase 1 |
0.7419 | Intermediate Similarity | NPD1130 | Approved |
0.7419 | Intermediate Similarity | NPD1132 | Approved |
0.7419 | Intermediate Similarity | NPD6405 | Approved |
0.7419 | Intermediate Similarity | NPD829 | Discontinued |
0.7419 | Intermediate Similarity | NPD1136 | Approved |
0.7414 | Intermediate Similarity | NPD2226 | Clinical (unspecified phase) |
0.7398 | Intermediate Similarity | NPD9536 | Phase 1 |
0.7398 | Intermediate Similarity | NPD9537 | Phase 1 |
0.7395 | Intermediate Similarity | NPD2235 | Phase 2 |
0.7395 | Intermediate Similarity | NPD2231 | Phase 2 |
0.7391 | Intermediate Similarity | NPD9087 | Approved |
0.736 | Intermediate Similarity | NPD3062 | Approved |
0.736 | Intermediate Similarity | NPD3061 | Approved |
0.736 | Intermediate Similarity | NPD3059 | Approved |
0.7333 | Intermediate Similarity | NPD4659 | Approved |
0.7302 | Intermediate Similarity | NPD555 | Phase 2 |
0.7295 | Intermediate Similarity | NPD599 | Approved |
0.7295 | Intermediate Similarity | NPD859 | Approved |
0.7295 | Intermediate Similarity | NPD257 | Approved |
0.7295 | Intermediate Similarity | NPD858 | Approved |
0.7295 | Intermediate Similarity | NPD602 | Approved |
0.7295 | Intermediate Similarity | NPD258 | Approved |
0.729 | Intermediate Similarity | NPD289 | Clinical (unspecified phase) |
0.7288 | Intermediate Similarity | NPD2667 | Approved |
0.7288 | Intermediate Similarity | NPD2668 | Approved |
0.7265 | Intermediate Similarity | NPD1759 | Phase 1 |
0.7258 | Intermediate Similarity | NPD9718 | Approved |
0.725 | Intermediate Similarity | NPD2337 | Clinical (unspecified phase) |
0.7244 | Intermediate Similarity | NPD3052 | Approved |
0.7244 | Intermediate Similarity | NPD823 | Approved |
0.7244 | Intermediate Similarity | NPD817 | Approved |
0.7244 | Intermediate Similarity | NPD2568 | Approved |
0.7244 | Intermediate Similarity | NPD3054 | Approved |
0.7244 | Intermediate Similarity | NPD5314 | Approved |
0.7222 | Intermediate Similarity | NPD854 | Approved |
0.7222 | Intermediate Similarity | NPD855 | Approved |
0.7213 | Intermediate Similarity | NPD4103 | Phase 2 |
0.7213 | Intermediate Similarity | NPD4104 | Clinical (unspecified phase) |
0.7188 | Intermediate Similarity | NPD3553 | Approved |
0.7188 | Intermediate Similarity | NPD3552 | Approved |
0.7188 | Intermediate Similarity | NPD3554 | Approved |
0.7188 | Intermediate Similarity | NPD3555 | Approved |
0.7179 | Intermediate Similarity | NPD1758 | Phase 1 |
0.7177 | Intermediate Similarity | NPD2614 | Approved |
0.7177 | Intermediate Similarity | NPD596 | Approved |
0.7177 | Intermediate Similarity | NPD600 | Approved |
0.7154 | Intermediate Similarity | NPD558 | Phase 2 |
0.7132 | Intermediate Similarity | NPD6867 | Clinical (unspecified phase) |
0.7132 | Intermediate Similarity | NPD6866 | Clinical (unspecified phase) |
0.7115 | Intermediate Similarity | NPD1814 | Approved |
0.7115 | Intermediate Similarity | NPD1812 | Approved |
0.7097 | Intermediate Similarity | NPD3635 | Approved |
0.7097 | Intermediate Similarity | NPD3636 | Approved |
0.7097 | Intermediate Similarity | NPD3637 | Approved |
0.7083 | Intermediate Similarity | NPD9088 | Approved |
0.7083 | Intermediate Similarity | NPD3421 | Phase 3 |
0.7083 | Intermediate Similarity | NPD1671 | Clinical (unspecified phase) |
0.7083 | Intermediate Similarity | NPD1980 | Approved |
0.7083 | Intermediate Similarity | NPD1983 | Approved |
0.7083 | Intermediate Similarity | NPD1981 | Approved |
0.708 | Intermediate Similarity | NPD3021 | Approved |
0.708 | Intermediate Similarity | NPD3022 | Approved |
0.7077 | Intermediate Similarity | NPD7450 | Phase 2 |
0.7077 | Intermediate Similarity | NPD1538 | Phase 1 |
0.7077 | Intermediate Similarity | NPD9570 | Approved |
0.7077 | Intermediate Similarity | NPD1632 | Clinical (unspecified phase) |
0.7077 | Intermediate Similarity | NPD1519 | Approved |
0.7077 | Intermediate Similarity | NPD1537 | Approved |
0.7064 | Intermediate Similarity | NPD4818 | Approved |
0.7064 | Intermediate Similarity | NPD4817 | Approved |
0.7063 | Intermediate Similarity | NPD3056 | Clinical (unspecified phase) |
0.7049 | Intermediate Similarity | NPD2428 | Approved |
0.7049 | Intermediate Similarity | NPD2429 | Approved |
0.7049 | Intermediate Similarity | NPD3676 | Clinical (unspecified phase) |
0.7043 | Intermediate Similarity | NPD821 | Approved |
0.704 | Intermediate Similarity | NPD3594 | Approved |
0.704 | Intermediate Similarity | NPD2606 | Approved |
0.704 | Intermediate Similarity | NPD2605 | Approved |
0.704 | Intermediate Similarity | NPD3595 | Approved |
0.7025 | Intermediate Similarity | NPD5350 | Clinical (unspecified phase) |
0.7025 | Intermediate Similarity | NPD5351 | Clinical (unspecified phase) |
0.7023 | Intermediate Similarity | NPD7978 | Discontinued |
0.7023 | Intermediate Similarity | NPD2029 | Clinical (unspecified phase) |
0.7023 | Intermediate Similarity | NPD6809 | Clinical (unspecified phase) |
0.7018 | Intermediate Similarity | NPD9280 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD2554 | Approved |
0.7 | Intermediate Similarity | NPD4658 | Approved |
0.7 | Intermediate Similarity | NPD3680 | Approved |
0.7 | Intermediate Similarity | NPD3683 | Approved |
0.7 | Intermediate Similarity | NPD3682 | Approved |
0.7 | Intermediate Similarity | NPD4656 | Approved |
0.7 | Intermediate Similarity | NPD4229 | Approved |
0.7 | Intermediate Similarity | NPD2556 | Approved |
0.7 | Intermediate Similarity | NPD4231 | Approved |
0.7 | Intermediate Similarity | NPD3681 | Approved |
0.6984 | Remote Similarity | NPD5155 | Approved |
0.6984 | Remote Similarity | NPD5156 | Approved |
0.6979 | Remote Similarity | NPD9294 | Approved |
0.6972 | Remote Similarity | NPD3028 | Approved |
0.6957 | Remote Similarity | NPD228 | Approved |
0.6953 | Remote Similarity | NPD826 | Approved |
0.6953 | Remote Similarity | NPD825 | Approved |
0.6947 | Remote Similarity | NPD1523 | Approved |
0.6947 | Remote Similarity | NPD1522 | Approved |
0.6937 | Remote Similarity | NPD179 | Clinical (unspecified phase) |
0.6935 | Remote Similarity | NPD1820 | Approved |
0.6935 | Remote Similarity | NPD1819 | Approved |
0.6935 | Remote Similarity | NPD1818 | Approved |
0.6935 | Remote Similarity | NPD1817 | Approved |
0.6923 | Remote Similarity | NPD475 | Phase 2 |
0.6923 | Remote Similarity | NPD1536 | Approved |
0.6917 | Remote Similarity | NPD3049 | Approved |
Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
☉ A: chemistry similarity;
☉ B: biological targets similarity;
☉ C: networks similarity;
☉ D: cell-based bioactivity similarity;
☉ E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.